An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device

NCT01651650 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DEVICE: Inhalation through Chiesi NEXThaler DPI

Sponsor

Chiesi Farmaceutici S.p.A.